The miR-30 family plays dual roles in cancer, acting as tumour promoters in pancreatic cancer by enhancing the migratory and invasive capacities of CD133+ cells, while functioning as tumour suppressors in lung, breast, and gastric cancers [155]. Here, PROM1 is linked to cancer.